Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

Overview of attention for article published in Neurotherapeutics, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#30 of 1,308)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 18 news outlets
twitter: 4 X users
facebook: 2 Facebook pages

wikipedia: 1 Wikipedia page
googleplus: 1 Google+ user

Citations

dimensions_citation: 90 Dimensions

Readers on

mendeley: 117 Mendeley

Summary News X Facebook Wikipedia Google+ Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

Cuadernos de Neuropsicologia, 22 Nov 2017

La neuropatía periférica, complicación de la quimioterapia puede suponer suspensión precoz del tratamiento

Medicina Del Dolore Aisd, 26 Oct 2017

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlle…